The top twenty significant pathways mainly included the ErbB signaling pathway, microRNA in cancer, Neurotrophin signaling pathway, EGFR tyrosine kinase inhibitor resistance and p53 signaling pathway. This evidence concerns the gene EGFR and cancer.